Search

Your search keyword '"Bentata, M"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Bentata, M" Remove constraint Author: "Bentata, M"
125 results on '"Bentata, M"'

Search Results

1. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

2. Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection

4. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

6. Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

7. Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

8. Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection

14. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

15. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

16. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

17. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

18. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

19. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

20. Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country

21. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

22. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

26. Déterminants de la non prise en charge diagnostiqueet thérapeutique des personnes à risque d'infection par le virus de l'hépatite C (VHC), consultant dans les réseaux de soins spécialisés: étude GYMKHANA

37. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119)

39. Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

40. Survival after neuroAIDS

41. Impact of Newly Available Drugs on Clinical Progression in Patients with Virological Failure after Exposure to Three Classes of Antiretrovirals

42. Salvage Therapy with Amprenavir, Lopinavir and Ritonavir 200 Mg/D or 400 Mg/D in HIV-Infected Patients in Virological Failure

43. Impact of Insertions in the HIV-1 P6 Ptapp Region on the Virological Response to Amprenavir

44. Triple Nucleoside Combination Zidovudine/Lamivudine/Abacavir versus Zidovudine/Lamivudine/Nelfinavir as First-Line Therapy in HIV-1-Infected Adults: A Randomized Trial

46. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

49. Study of AZT and AMT plasma concentrations and their relationship with haematological toxicity

Catalog

Books, media, physical & digital resources